Spero Therapeutics, Inc.SPRONASDAQ
Loading
Expenses from normal business operations (SG&A, R&D, etc.)
Percentile
P0
Near historical low
vs 5Y Ago
-1.2x
Contraction
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-25.66M | -204.4% |
| 2024 | $24.58M | -20.3% |
| 2023 | $30.86M | -66.0% |
| 2022 | $90.78M | -0.3% |
| 2021 | $91.04M | +324.6% |
| 2020 | $21.44M | +37.5% |
| 2019 | $15.59M | -63.6% |
| 2018 | $42.81M | +2.6% |
| 2017 | $41.73M | +24.4% |
| 2016 | $33.56M | - |